UHS vs ENSG vs DVA
161 measures in 16 categories, one definition each, computed from filings and market data.
UHS61.1
Universal Health Services, Inc.
Healthcare · Medical - Care Facilities
$185.10 −1.18%$10.9B mkt cap
Score DNA
ENSG65.5
The Ensign Group, Inc.
Healthcare · Medical - Care Facilities
$176.63 −0.83%$10.3B mkt cap
Score DNA
Price, rebased to 100 three years ago
UHS ENSG DVA · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | UHS | ENSG | DVA |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 0 |
| Insider $ bought, 180d | — | — | — |
| Congress purchases, 180d | 1 | 0 | 1 |
| Last Congress purchase | 2026-03-27 | — | 2026-03-27 |
| 13F net change in holders | −56 | −20 | — |
| ETFs adding shares, 30d | 455 | 279 | 537 |
| ETFs trimming, 30d | 501 | 239 | 381 |
| Net ETF funds, 30d | −46 | +40 | +156 |
Valuation
16 measures| Measure | UHS | ENSG | DVA |
|---|---|---|---|
| P/E (TTM) | 7.1x
4th
|
27.2x
78th
|
14.1x
30th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 0.19
8th
|
1.83
85th
|
0.38
23rd
|
| Price / sales | 0.6x
19th
|
1.9x
78th
|
0.9x
34th
|
| Price / book | 1.5x
14th
|
4.2x
64th
|
— |
| Price / tangible book | 2.5x
0th
|
4.1x
38th
|
— |
| Price / free cash flow | 13.2x
37th
|
24.6x
78th
|
7.4x
15th
|
| Price / operating cash flow | 6.1x
24th
|
16.9x
76th
|
5.4x
17th
|
| Enterprise value | $16.0B
91st
|
$12.2B
84th
|
$22.0B
94th
|
| EV / sales | 0.9x
19th
|
2.2x
78th
|
1.6x
50th
|
| EV / EBITDA | 5.7x
7th
|
19.7x
79th
|
8.0x
25th
|
| EV / EBIT | 7.4x
7th
|
24.1x
78th
|
10.7x
30th
|
| EV / free cash flow | 19.4x
41st
|
29.2x
78th
|
13.7x
26th
|
| Earnings yield | 14.0%
97th
|
3.7%
44th
|
7.1%
78th
|
| FCF yield | 7.6%
69th
|
4.1%
34th
|
13.5%
88th
|
| Operating cash flow yield | 16.5%
78th
|
5.9%
31st
|
18.4%
84th
|
| Graham number (per share) | $267.97
100th
|
$76.68
71st
|
— |
Profitability (TTM)
12 measures| Measure | UHS | ENSG | DVA |
|---|---|---|---|
| Gross margin | 90.7%
100th
|
14.1%
9th
|
31.0%
66th
|
| EBITDA margin | 15.6%
69th
|
11.3%
50th
|
19.7%
78th
|
| Operating margin | 11.4%
72nd
|
8.5%
53rd
|
15.1%
84th
|
| EBIT margin | 12.0%
66th
|
9.2%
53rd
|
14.7%
78th
|
| Net margin | 8.4%
69th
|
6.9%
62nd
|
6.0%
56th
|
| NOPAT margin | 8.7%
69th
|
6.5%
53rd
|
11.9%
81st
|
| FCF margin | 4.6%
28th
|
7.6%
56th
|
11.5%
78th
|
| Operating cash flow margin | 9.9%
47th
|
11.1%
62nd
|
15.7%
88th
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 46.7%
91st
|
5.4%
9th
|
12.4%
41st
|
| Stock comp / revenue | 0.3%
17th
|
1.0%
67th
|
0.9%
60th
|
| Effective tax rate | 23.5%
61st
|
24.0%
65th
|
20.7%
23rd
|
Returns on capital
11 measures| Measure | UHS | ENSG | DVA |
|---|---|---|---|
| ROE (on average equity) | 21.0%
69th
|
17.0%
62nd
|
— |
| ROA | 9.9%
78th
|
7.1%
56th
|
4.8%
44th
|
| ROIC | 12.5%
59th
|
8.1%
41st
|
17.9%
75th
|
| ROCE | 17.2%
78th
|
10.4%
44th
|
13.8%
56th
|
| Return on tangible assets | 14.1%
75th
|
9.5%
44th
|
11.7%
56th
|
| Cash ROIC (OCF / invested capital) | 14.2%
44th
|
13.9%
38th
|
23.5%
66th
|
| Gross profitability (GP / assets) | 103.1%
97th
|
13.5%
16th
|
24.5%
47th
|
| ROIC, 3-yr average | 9.2%
71st
|
7.1%
61st
|
9.8%
75th
|
| ROIC, 5-yr average | 9.5%
78th
|
9.3%
70th
|
— |
| ROE, 5-yr average | 15.5%
82nd
|
16.1%
86th
|
— |
| Incremental ROIC | 82.7%
55th
|
17.3%
45th
|
-41.6%
13th
|
Growth
17 measures| Measure | UHS | ENSG | DVA |
|---|---|---|---|
| Revenue growth (TTM YoY) | 10.0%
50th
|
18.9%
72nd
|
6.4%
34th
|
| Revenue growth (QoQ) | 3.2%
34th
|
3.7%
44th
|
4.1%
53rd
|
| Revenue CAGR, 3 yr | 9.5%
36th
|
17.4%
68th
|
6.1%
21st
|
| Revenue CAGR, 5 yr | 8.2%
35th
|
17.1%
69th
|
3.9%
19th
|
| Gross profit CAGR, 3 yr | 10.2%
44th
|
11.7%
48th
|
8.0%
36th
|
| Operating income CAGR, 3 yr | 23.4%
74th
|
15.6%
58th
|
18.0%
68th
|
| Net income growth (TTM YoY) | 21.0%
50th
|
17.3%
33rd
|
1.3%
17th
|
| Net income CAGR, 3 yr | 30.2%
73rd
|
16.3%
33rd
|
21.9%
47th
|
| EPS growth (TTM YoY) | 31.2%
56th
|
15.6%
22nd
|
18.6%
33rd
|
| EPS CAGR, 3 yr | 37.6%
80th
|
14.9%
33rd
|
36.8%
73rd
|
| EPS CAGR, 5 yr | 15.1%
57th
|
14.1%
50th
|
10.6%
43rd
|
| FCF growth (TTM YoY) | -8.3%
15th
|
51.4%
58th
|
24.9%
38th
|
| FCF CAGR, 3 yr | 17.5%
41st
|
26.2%
53rd
|
5.9%
24th
|
| Operating cash flow CAGR, 3 yr | 15.4%
39th
|
25.1%
61st
|
3.7%
17th
|
| Book value CAGR, 3 yr | 13.4%
68th
|
19.2%
77th
|
— |
| Dividend CAGR, 3 yr | 3.6%
56th
|
0.5%
33rd
|
— |
| Sustainable growth rate | 20.3%
52nd
|
16.3%
48th
|
— |
Margin history & stability
7 measures| Measure | UHS | ENSG | DVA |
|---|---|---|---|
| Gross margin, 3-yr average | 90.1%
100th
|
15.2%
14th
|
32.1%
59th
|
| Operating margin, 3-yr average | 10.7%
72nd
|
8.0%
59th
|
15.3%
90th
|
| Net margin, 3-yr average | 7.4%
83rd
|
6.5%
76th
|
6.4%
72nd
|
| FCF margin, 3-yr average | 5.2%
45th
|
6.2%
62nd
|
10.5%
93rd
|
| Revenue stability (0-1) | 0.97
83rd
|
0.98
86th
|
0.88
38th
|
| Earnings stability (0-1) | 0.45
72nd
|
0.86
93rd
|
0.01
10th
|
| Margin stability (0-1) | 0.99
100th
|
0.93
69th
|
0.96
83rd
|
Liquidity (latest quarter)
7 measures| Measure | UHS | ENSG | DVA |
|---|---|---|---|
| Cash & short-term investments | $138.8M
31st
|
$320.8M
72nd
|
$688.9M
88th
|
| Net cash (− = net debt) | −$5.1B
12th
|
−$1.9B
31st
|
−$10.1B
6th
|
| Working capital | $381.7M
78th
|
$186.7M
66th
|
$1.3B
97th
|
| Current ratio | 1.12
22nd
|
1.21
44th
|
1.47
69th
|
| Quick ratio | 1.04
22nd
|
1.21
47th
|
1.41
75th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.04
0th
|
0.36
44th
|
0.24
38th
|
| Defensive interval (days) | 75 days
3rd
|
1,171 days
87th
|
607 days
68th
|
Leverage & solvency (latest quarter)
13 measures| Measure | UHS | ENSG | DVA |
|---|---|---|---|
| Total debt | $5.3B
88th
|
$2.3B
69th
|
$10.8B
94th
|
| Debt / equity | 0.70
36th
|
0.92
50th
|
— |
| Net debt / equity | 0.68
46th
|
0.79
54th
|
— |
| Debt / assets | 33.0%
44th
|
39.1%
56th
|
60.9%
84th
|
| Debt / capital | 41.2%
36th
|
48.0%
50th
|
— |
| Debt / EBITDA | 1.87
29th
|
3.62
64th
|
3.90
71st
|
| Net debt / EBITDA | 1.82
39th
|
3.11
68th
|
3.65
75th
|
| Interest coverage (EBIT / interest) | 13.9x
70th
|
65.0x
87th
|
3.7x
33rd
|
| Cash interest coverage | 11.5x
57th
|
78.1x
90th
|
3.9x
33rd
|
| Debt payback (years of OCF) | 2.9 yrs
41st
|
3.7 yrs
52nd
|
4.9 yrs
66th
|
| Liabilities / assets | 52.0%
34th
|
57.5%
41st
|
93.9%
91st
|
| IS credit model rating | A | A+ | BB |
| Implied credit spread (bps) | 150
31st
|
125
25th
|
475
78th
|
Efficiency
11 measures| Measure | UHS | ENSG | DVA |
|---|---|---|---|
| Asset turnover | 1.17
56th
|
1.03
50th
|
0.80
25th
|
| Fixed asset turnover | 2.41
23rd
|
1.29
10th
|
2.70
32nd
|
| Inventory turnover | 7.4
0th
|
— | 64.9
67th
|
| Receivables turnover | 7.1
19th
|
8.8
47th
|
5.7
9th
|
| Days sales outstanding | 51 days
81st
|
41 days
53rd
|
64 days
91st
|
| Days inventory outstanding | 49 days
100th
|
— | 6 days
38th
|
| Days payables outstanding | 503 days
100th
|
9 days
22nd
|
25 days
53rd
|
| Cash conversion cycle (days) | −402 days
0th
|
33 days
78th
|
45 days
91st
|
| Capex / revenue | 5.4%
77th
|
3.5%
65th
|
4.2%
68th
|
| Capex / depreciation | 1.52
84th
|
1.65
87th
|
0.82
48th
|
| Operating expense ratio | 79.7%
100th
|
8.1%
19th
|
16.6%
53rd
|
Cash flow & earnings quality
7 measures| Measure | UHS | ENSG | DVA |
|---|---|---|---|
| Operating cash flow / net income | 1.18
9th
|
1.61
43rd
|
2.59
78th
|
| FCF / net income | 0.54
4th
|
1.11
30th
|
1.90
78th
|
| FCF / operating cash flow | 45.9%
18th
|
68.9%
39th
|
73.4%
46th
|
| Capex / operating cash flow | 54.1%
82nd
|
31.1%
61st
|
26.6%
54th
|
| Accruals ratio | -1.8%
94th
|
-4.3%
69th
|
-7.6%
34th
|
| Sloan accruals ratio | -6.0%
28th
|
-4.5%
38th
|
-3.0%
50th
|
| Earnings quality score (0-1) | 1.00
65th
|
1.00
65th
|
0.75
9th
|
Scores & forensic checks
15 measures| Measure | UHS | ENSG | DVA |
|---|---|---|---|
| IS score | 61
59th
|
65
78th
|
44
31st
|
| IS profitability | 60
91st
|
36
56th
|
30
41st
|
| IS growth | 63
47th
|
67
66th
|
56
25th
|
| IS value | 88
100th
|
50
53rd
|
51
62nd
|
| IS momentum | 86
53rd
|
92
78th
|
75
38th
|
| IS risk (safety) | 65
44th
|
80
56th
|
30
12th
|
| IS quality | 79
84th
|
70
66th
|
64
59th
|
| IS balance sheet | 61
66th
|
61
62nd
|
27
16th
|
| IS earnings quality | 79
81st
|
79
84th
|
63
34th
|
| IS cash flow | 40
28th
|
63
59th
|
64
62nd
|
| Piotroski F-score (0-9) | 8
78th
|
7
59th
|
8
78th
|
| Altman Z-score | 3.0
53rd
|
3.5
66th
|
1.8
16th
|
| Beneish M-score | −2.37
69th
|
−2.53
59th
|
−2.81
28th
|
| Ohlson O-score | −8.39
22nd
|
−7.52
34th
|
−5.68
84th
|
| IS credit score | 71
59th
|
75
72nd
|
44
22nd
|
Size (TTM)
8 measures| Measure | UHS | ENSG | DVA |
|---|---|---|---|
| Market cap | $10.9B
88th
|
$10.3B
84th
|
$12.0B
91st
|
| Revenue | $18.1B
91st
|
$5.5B
69th
|
$14.0B
88th
|
| EBITDA | $2.8B
91st
|
$621.3M
78th
|
$2.8B
88th
|
| Net income | $1.5B
94th
|
$378.7M
84th
|
$847.5M
91st
|
| Free cash flow | $826.7M
91st
|
$419.1M
84th
|
$1.6B
94th
|
| Total assets | $15.9B
91st
|
$5.7B
75th
|
$17.7B
94th
|
| Shareholders' equity | $7.5B
100th
|
$2.4B
91st
|
−$765.1M
6th
|
| Employees | 101,500
97th
|
46,000
78th
|
78,000
91st
|
Price performance
9 measures| Measure | UHS | ENSG | DVA |
|---|---|---|---|
| 1 day | −1.2% | −0.8% | −1.0% |
| 1 week | +4.4% | +2.8% | +4.5% |
| 1 month | +2.4% | +1.0% | +2.3% |
| 3 months | +22.9% | +2.7% | −20.0% |
| 6 months | +1.5% | −11.7% | +26.6% |
| Year to date | −15.7% | +1.6% | +63.6% |
| 1 year | −9.6% | −0.7% | +48.7% |
| 3 years, cumulative | +47.2% | +83.0% | +146.8% |
| 5 years, cumulative | +45.1% | +145.8% | +65.4% |
Technicals
4 measures| Measure | UHS | ENSG | DVA |
|---|---|---|---|
| RSI 14 | 63.5 | 55.7 | 57.6 |
| From 52-week high | −24.8% | −19.0% | −24.3% |
| From 52-week low | +32.2% | +24.8% | +85.5% |
| Beta | 1.03 | 0.66 | 0.80 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17